Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 High Quality Stocks to Buy According to Hedge Funds

In this article, we will take a look at some of the best 5 High Quality Stocks to Buy According to Hedge Funds. For deeper discussion and analysis, read 10 High Quality Stocks to Buy According to Hedge Funds. 

5. Caterpillar Inc. (NYSE:CAT)

Number of Hedge Fund Holders: 86

On May 11, Evercore ISI analyst David Raso raised the price recommendation on Caterpillar Inc. (NYSE:CAT) to $1,103 from $878. The analyst reiterated an Outperform rating on the stock.

During the company’s Q1 2026 earnings call, Chairman and CEO Creed said Caterpillar now expected full-year 2026 sales and revenue growth in the low double digits. He also said the company was not expecting any material impact on its 2026 outlook at this stage, even with ongoing geopolitical uncertainty and higher energy prices.

Senior Vice President Kyle Epley said the company had lowered its estimate for full-year 2026 tariff costs to between $2.2 billion and $2.4 billion. That was down from the earlier estimate of $2.6 billion shared last quarter. He added that the company planned to increase efforts to offset tariff-related costs in the second half of the year.

Epley also said Caterpillar still expected restructuring charges of about $300 million to $350 million in 2026. The company’s capital expenditure forecast remained around $3.5 billion. He added that MP&E’s free cash flow was now expected to top the $9.5 billion reported last year.

Caterpillar Inc. (NYSE:CAT) makes construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives.

4. CVS Health Corporation (NYSE:CVS)

Number of Hedge Fund Holders: 88

On May 13, Bernstein raised its price recommendation on CVS Health Corporation (NYSE:CVS) to $106 from $94. It reiterated an Outperform rating on the stock. The firm said it still sees CVS as well-positioned to benefit from the Medicare Advantage turnaround. It also pointed to the possibility of steadier earnings in the company’s pharmacy and pharmacy benefit manager businesses following PBM reform. Bernstein believes the PBM bill and the first Federal Trade Commission settlement earlier this year largely marked the completion of PBM reform. In its view, that served as a clearing event and reduced uncertainty around CVS’ turnaround efforts.

During the company’s Q1 2026 earnings call, CEO, President, and Chairman J. Joyner said CVS generated adjusted operating income of $5.2 billion and adjusted earnings per share of $2.57. He said the quarter’s results supported a stronger outlook for 2026, prompting the company to raise its full-year adjusted EPS guidance to between $7.30 and $7.50, up from the prior range of $7 to $7.20. Joyner also said the Final Rate Notice issued in April represented progress toward improving sustainability, though it still did not fully offset underlying medical cost pressures. He noted that industry cost trends remained above historical averages, and CVS would continue taking measures to improve Medicare Advantage margins.

Looking ahead, Joyner said CVS plans to launch Health100 later this year. He described it as an AI-native technology and service platform aimed at helping payers, PBMs, pharmacies, and providers connect more smoothly. According to him, the platform is intended to serve as a consumer-facing entry point that creates a more integrated healthcare experience.

CVS Health Corporation (NYSE:CVS) is a health solutions company with segments that include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other.

3. The Home Depot, Inc. (NYSE:HD)

Number of Hedge Fund Holders: 98

On May 20, DA Davidson analyst Michael Baker lowered the firm’s price recommendation on The Home Depot, Inc. (NYSE:HD) to $377 from $445. It reiterated a Buy rating on the shares. The analyst noted that the stock turned slightly positive after its initial post-earnings decline. He said that may have been tied to commentary during the earnings call, suggesting that May trends improved after sales weakened in the second half of April, apparently due to weather conditions. Baker also said the recent rise in interest rates is likely to delay the timing of a broader macro recovery. That view was reflected in the firm’s reduced price target.

The same day, RBC Capital analyst Steven Shemesh lowered the firm’s price target on HD to $340 from $377 and kept a Sector Perform rating on the stock following its Q1 results. He said the company posted a modest Q1 earnings beat, though housing turnover remained stalled while the demand and cost outlook weakened. According to Shemesh, RBC continues to struggle to identify a catalyst that could push Home Depot’s results meaningfully higher.

The Home Depot, Inc. (NYSE:HD) is a home improvement retailer that sells home improvement products, building materials, lawn and garden products, decor items, and maintenance, repair, and operations products through its stores and online platform.

2. Walmart Inc. (NASDAQ:WMT)

Number of Hedge Fund Holders: 114

On May 22, BofA lowered its price target on Walmart Inc. (NASDAQ:WMT) to $144 from $150. It reiterated a Buy rating on the shares. The firm said it reduced its valuation multiple after earnings because of a more challenging consumer environment. Even so, BofA believes Walmart could continue gaining market share as consumers become more price-conscious. The firm said that trend “should drive a return to a beat/raise cycle assuming the freight environment doesn’t worsen.”

On May 15, Piper Sandler analyst Peter Keith raised the firm’s price target on WMT to $137 from $130 and maintained an Overweight rating on the stock. The firm said investors have become concerned about consumer discretionary spending because of higher gas prices, though consumer spending has remained resilient. Piper Sandler also noted that tax refunds stood out during Q1, but there has been no clear sign that those funds significantly boosted retail spending. According to the firm, middle- and upper-income consumers likely chose to save that money instead. For the home improvement sector, the firm said the sluggish trends seen in Q4 appeared to continue into the latest quarter.

Walmart Inc. (NASDAQ:WMT) is a technology-powered omnichannel retailer that operates retail and wholesale stores, clubs, eCommerce websites, and mobile applications across the U.S., Africa, Canada, Central America, Chile, China, India, and Mexico.

1. UnitedHealth Group Incorporated (NYSE:UNH)

Number of Hedge Fund Holders: 145

On May 22, UBS analyst AJ Rice raised the firm’s price recommendation on UnitedHealth Group Incorporated (NYSE:UNH) to $460 from $410. He reiterated a Buy rating on the shares. The analyst said managed care organizations broadly increased guidance after stronger-than-expected Q1 results benefited from favorable respiratory trends and seasonal cost patterns. Rice also noted that improved Medicare Advantage rates, more stable ACA exchange enrollment, and modest outperformance in Medicaid have increased confidence in margin recovery. At the same time, he said the sector continues to face cost pressures tied to specialty drugs, GLP-1s, and behavioral health.

On May 13, BofA analyst Kevin Fischbeck raised the firm’s price goal on UNH to $420 from $380. He maintained a Neutral rating on the stock. According to the analyst, the tone of discussions with the company’s leadership team at the BofA Healthcare Conference was “bullish.” Fischbeck said the company appeared confident that it could return to at least the low end of its target margins across most businesses by 2028.

UnitedHealth Group Incorporated (NYSE:UNH) is a healthcare and well-being company with operations across Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. Its UnitedHealthcare segment includes Employer & Individual, Medicare & Retirement, and Community & State businesses.

While we acknowledge the potential of UNH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best Long Term Low Risk Stocks to Buy According to Hedge Funds and 11 Best Long Term US Stocks to Buy Right Now

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.